al ideation. Mild liver impairment (Child-Pugh Class A). Monitor for insomnia, anxiety, depression, suicidal ideation, other mood changes; reeva luate if occurs. Monitor weight regularly; consider discontinuing if unexplained or significant weight loss occurs. Pregnancy (Cat. C). Labor & delivery, nursing mothers: not recommended.
Interaction(s):
Concomitant strong CYP450 inducers (eg, rifampicin, phenobarbital, carbamazepine, phenytoin): not recommended. Potentiated by CYP3A4 and CYP1A2 inhibitors (eg, erythromycin, ketoconazole, fluvoxamine, enoxacin, cimetidine), and by oral contraceptives containing gestodene + ethinyl estradiol (possible increased adverse effects).
Adverse Reaction(s):
GI upset, weight decrease, headache, back pain, influenza, dizziness, decreased appetite; psychiatric effects (eg, insomnia, anxiety, depression).
How Supplied:
Tabs—30
Last Updated:
6/16/2011
详情可以浏览http://www.daxas.com/
---------------------------------------------------------------
原产地英文商品名:
DAXAS 500mcg/tab 30tabs/box
原产地英文药品名:
ROFLUMILAST
原产地英文化合物名称:
3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide
中文参考商品译名:
DAXAS 500微克/片 30片/盒
中文参考药品译名:
罗氟司特
中文参考化合物名称:
3-(环丙基甲氧基)-N-(3,5-二氯吡啶-4-基)-4-(二氟甲氧基)苯甲酰胺
生产厂家中文参考译名:
奈科明英国制药
生产厂家英文名:
NYCOMED UK LTD
该药品相关信息网址1:
http://www.msd-ireland.com/
该药品相关信息网址2:
http://www.meerburgpharmacy.com/daxas.htm
|
